1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2015 Europe HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic a

Complete report $3,950.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.

Summary

This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK).  For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot,
HTLV-I/II and other confirmatory tests performed in the following market segments:

     - Hospitals
     - Commercial/Private Laboratories
     - Blood Banks
     - Public Health Laboratories

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho- Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments.  The database contains information on companies, technologies, products and executives worldwide.  Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 277 pages and 31 tables

This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

Table Of Contents

2015 Europe HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic a
I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo , HIVAg/HIV NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers'
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VI. Spain: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VII. UK: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VIII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
IX. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

X. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako
LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests

France: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

France: HIV Ag Test Volume and Sales Forecasts
By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales

France: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Germany: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Germany: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales

Germany: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment

Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major
Suppliers

Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Italy: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales

Italy: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment

Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Spain: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment

Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

UK: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

UK: HIV Ag Test Volume and Sales Forecasts
By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment

UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s AIDS Related Kaposi’s Sarcoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2014 - 2025

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one ...


Download Unlimited Documents from Trusted Public Sources

Tuberculosis Statistics

  • February 2017
    200 pages
  • Infectious Dise...  

    Tuberculosis  

  • United States  

    North America  

    Europe  

View report >

Dementia Statistics and Infectious Disease Statistics

  • February 2017
    141 pages
  • Dementia  

    Infectious Dise...  

    Healthcare  

  • Asia  

View report >

HIV AIDS Statistics in South Africa

  • February 2017
    8 pages
  • HIV AIDS  

    Food  

  • South Africa  

View report >

Related Market Segments :

HIV AIDS

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.